| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2010 | WO2010126137A1 Anti-cadherin antibody |
| 04/10/2010 | CA2685615A1 Single cell microinjection using flexible and compliant fluidic channels and electroosomotic dosage control |
| 04/08/2010 | WO2010040134A2 Independently inducible system of gene expression |
| 04/08/2010 | WO2010040112A2 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
| 04/08/2010 | WO2010040091A1 Novel dna nanostructures that promote cell-cell interaction and use thereof |
| 04/08/2010 | WO2010040033A2 Methods and compositions for modulating an immune response with immunogenic oligonucleotides |
| 04/08/2010 | WO2010040023A2 Methods and compositions for protein delivery |
| 04/08/2010 | WO2010039991A2 Method of generating informative dna templates for high-throughput sequencing applications |
| 04/08/2010 | WO2010039934A1 Bovine herpes virus -1 compositions, vaccines and methods |
| 04/08/2010 | WO2010039900A2 Non-human mammals for the production of chimeric antibodies |
| 04/08/2010 | WO2010039840A1 Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum |
| 04/08/2010 | WO2010039802A2 Methods and compositions for isolating nucleic acid |
| 04/08/2010 | WO2010039778A2 Mammalian genes involved in infection |
| 04/08/2010 | WO2010039750A2 Transgenic plants with enhanced agronomic traits |
| 04/08/2010 | WO2010039692A2 Transformed saccharomyces cerevisiae engineered for xylose utilization |
| 04/08/2010 | WO2010039649A2 Flavivirus-based system for production of hepatitis c virus (hcv) |
| 04/08/2010 | WO2010039615A2 Papio cynocephalus toll-like receptor 3 |
| 04/08/2010 | WO2010039543A2 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference |
| 04/08/2010 | WO2010039224A2 Respiratory syncytial virus (rsv) sequences for protein expression and vaccines |
| 04/08/2010 | WO2010038965A2 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 04/08/2010 | WO2010038904A1 Induced pluripotent stem cell free of exogenous nuclear reprogramming factor or dna encoding the factor and method for producing the cell |
| 04/08/2010 | WO2010038903A1 A method for producing purine ribonucleosides and ribonucleotides |
| 04/08/2010 | WO2010038840A1 METHOD FOR PREDICTING PHARMACOLOGICAL EFFICACY OF ANTI-TNFα ANTIBODY PREPARATION ON RHEUMATOID ARTHRITIS, AND PHARMACOLOGICAL EFFICACY PREDICTION APPARATUS |
| 04/08/2010 | WO2010038831A1 Method, composition and kit for detecting diabetic complications accompanied by cell proliferation |
| 04/08/2010 | WO2010038830A1 Method, composition and kit for detecting tissue disorders induced by atrophy of collagen fibers |
| 04/08/2010 | WO2010038802A1 Host, transformant, method for producing the transformant, and method for producing heterogeneous protein containing o-glycoside type sugar chain |
| 04/08/2010 | WO2010038789A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
| 04/08/2010 | WO2010038778A1 Nucleic acid extraction stabilizer, nucleic acid extraction method, and nucleic acid extraction apparatus |
| 04/08/2010 | WO2010038613A1 Method for producing chemical and continuous culture system |
| 04/08/2010 | WO2010038579A1 Process for producing microbeads and microbeads |
| 04/08/2010 | WO2010038158A1 Production of ngf in plant |
| 04/08/2010 | WO2010038145A2 Kit for the optimisation of protein synthesis/secretion |
| 04/08/2010 | WO2010038083A2 Transcription factor decoys |
| 04/08/2010 | WO2010038010A1 Somatostatin analogues |
| 04/08/2010 | WO2010037714A1 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance biotic stress |
| 04/08/2010 | WO2010037593A1 Tetracycline inducible transcription control sequence |
| 04/08/2010 | WO2010037403A1 Hepatitis c virus expressing reporter tagged ns5a protein |
| 04/08/2010 | WO2010037351A1 Peptide antagonist of interleukin-15 activity |
| 04/08/2010 | WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof |
| 04/08/2010 | WO2010037209A1 Production of modified fatty acids in plants |
| 04/08/2010 | WO2010037208A1 Production of products of pharmaceutical interest in plant cell cultures |
| 04/08/2010 | WO2010037181A1 Cell therapy and compositions therefor |
| 04/08/2010 | WO2010019386A3 Protein production in plant cells and associated methods and compositions |
| 04/08/2010 | WO2010011961A9 Prokaryotic rnai-like system and methods of use |
| 04/08/2010 | WO2010009203A3 Lateral flow nucleic acid detector |
| 04/08/2010 | WO2009155504A9 Methods for the modulation of angiogenesis |
| 04/08/2010 | WO2009149921A3 Inhibition of hrp-3 using modified oligonucleotides |
| 04/08/2010 | WO2009138146A3 Novel therapeutic agents against hepatitis |
| 04/08/2010 | WO2009117122A8 Genetic analysis |
| 04/08/2010 | WO2009083790A3 'apoptosis inducing positive control for expression modulating experiments' |
| 04/08/2010 | WO2009072005A3 Cxcl12 gamma a chemokine and uses thereof |
| 04/08/2010 | WO2009071334A3 Transposon-mediated mutagenesis in spermatogonial stem cells |
| 04/08/2010 | WO2008100424A3 Animals and cells with genomic target sites for transposase-mediated transgenesis |
| 04/08/2010 | US20100088786 Leaf-specific chlorophyll a/b binding protein gene promoter from oil palm |
| 04/08/2010 | US20100088785 Compositions and methods for modulating expression of gene products |
| 04/08/2010 | US20100088784 Sugar and lipid metabolism regulators in plants iii |
| 04/08/2010 | US20100088783 Nucleic acid molecules encoding sucrose synthase-like polypeptides and methods of use |
| 04/08/2010 | US20100088782 Seed enhancement by combinations of pyruvate kinases |
| 04/08/2010 | US20100088781 Altering carotenoid profiles in plants |
| 04/08/2010 | US20100088780 Convenient Method for Inhibition of Gene Expression Using RSIS |
| 04/08/2010 | US20100088778 Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene |
| 04/08/2010 | US20100088777 Methods For Increasing The Resistance In Plants To Biotropic Fungi |
| 04/08/2010 | US20100088776 Processes for producing polyunsaturated fatty acids in transgenic organisms |
| 04/08/2010 | US20100088774 Characterization of granulocytic ehrlichia and methods of use |
| 04/08/2010 | US20100087677 Compositions of tRNA and Uses Thereof |
| 04/08/2010 | US20100087624 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/08/2010 | US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 04/08/2010 | US20100087529 Perhydrolases for enzymatic peracid generation |
| 04/08/2010 | US20100087514 Method and means for treatment of osteoarthritis |
| 04/08/2010 | US20100087513 Microrna molecules |
| 04/08/2010 | US20100087512 Microrna molecules |
| 04/08/2010 | US20100087511 Spinal muscular atrophy (sma) treatment via targeting of smn2 splice site inhibitory sequences |
| 04/08/2010 | US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 04/08/2010 | US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
| 04/08/2010 | US20100087508 Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes |
| 04/08/2010 | US20100087507 Use of rpn2 gene expression inhibitor |
| 04/08/2010 | US20100087379 Polypeptides of botryosphaeria rhodina |
| 04/08/2010 | US20100087377 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; copper binding protein; inhibit the development of premalignant lesions in mammalian tissue |
| 04/08/2010 | US20100087371 Transglutaminase Variants with Improved Specificity |
| 04/08/2010 | US20100087353 Novel Variant EGIII-Like Cellulase Compositions |
| 04/08/2010 | US20100087336 Functional nucleic acids and methods |
| 04/08/2010 | US20100087335 siRNA targeting spleen tyrosine kinase |
| 04/08/2010 | US20100087334 siRNA targeting superoxide dismutase 1 (SOD1) |
| 04/08/2010 | US20100087006 Use of fluorescent protein in cyanobacteria and algae for improving photosynthesis and preventing cell damage |
| 04/08/2010 | US20100087005 Auxiliary reagent for gene transfer |
| 04/08/2010 | US20100086995 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen |
| 04/08/2010 | US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 04/08/2010 | US20100086984 Optoinjection methods |
| 04/08/2010 | US20100086973 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 04/08/2010 | US20100086972 Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports |
| 04/08/2010 | US20100086967 Cell growth |
| 04/08/2010 | US20100086966 Feedback resistant acetohydroxy acid synthethase mutants |
| 04/08/2010 | US20100086965 Metabolic engineering of arabinose-fermenting yeast cells |
| 04/08/2010 | US20100086949 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/08/2010 | US20100086919 Devices and methods for immunoglobulin production |
| 04/08/2010 | US20100086917 Isolated polynucleotides, nucleic acid constructs, methods and kits for localization of rna and/or polypeptides within living cells |
| 04/08/2010 | US20100086610 Vault and vault-like carrier molecules |
| 04/08/2010 | US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/08/2010 | US20100086565 Vectors for expression of hml-2 polypeptides |
| 04/08/2010 | US20100086564 West Nile Virus Vaccine |